Valuation: Takeda Pharmaceutical Company Limited

Market Cap 9,00400Cr 5.7TCr 5.08TCr 4.74TCr 4.31TCr 8.12TCr 5,48800Cr 8.18TCr 57TCr 22TCr 2,80100Cr 21TCr 21TCr P/E 2027 *
44.6x
P/E 2028 * 28.4x
Enterprise Value 12,91100Cr 8.17TCr 7.29TCr 6.79TCr 6.18TCr 12TCr 7,87000Cr 12TCr 82TCr 32TCr 4,01700Cr 31TCr 30TCr EV / Sales 2027 *
2.74x
EV / Sales 2028 * 2.65x
Free-Float
99.25%
Yield 2027 *
3.62%
Yield 2028 * 3.7%
1 day-0.07%
1 week-5.53%
Current month-2.44%
1 month-1.98%
3 months+5.22%
6 months-2.81%
Current year+16.63%
1 week 5,606
Extreme 5606
5,868
1 month 5,557
Extreme 5557
6,030
Current year 4,710
Extreme 4710
6,033
1 year 4,102
Extreme 4102
6,033
3 years 3,852
Extreme 3852
6,033
5 years 2,993
Extreme 2993
6,033
10 years 2,894.5
Extreme 2894.5
6,693
Manager TitleAgeSince
Chief Executive Officer 56 01/01/2025
Director of Finance/CFO 48 01/04/2024
Chief Tech/Sci/R&D Officer 48 01/02/2022
Director TitleAgeSince
Director/Board Member 61 01/06/2015
Director/Board Member 73 01/01/2019
Director/Board Member 48 01/06/2024
Date Insider Type Main position Quantity % Market Cap. Importance
14/09/26 Sell

Executive/Senior Manager

-34,535 0.0022%
02/09/26 Sell

Chief Technology Officer

-1,16,191 0.0073%
19/08/26 Sell

Chief Technology Officer

-19,651 0.0012%
Change 5-day change 1-year change 3-year change Capi.($)
-0.07%-5.53%+32.43%+29.57% 5.71TCr
+1.09%-2.58%+36.59%+113.17% 1,01900Cr
-0.77%-6.68%+34.87%+61.50% 62TCr
+0.38%-0.91%+14.62%+78.94% 46TCr
-2.79%-5.66%+57.97%+35.40% 36TCr
+0.93%-1.83%+20.98%+41.43% 33TCr
+0.12%-4.05%+10.09%+33.53% 27TCr
-0.89%-5.83%-7.56%+7.91% 24TCr
+0.08%-3.59%+37.06%+52.08% 22TCr
-0.31%-5.20%+27.05%+93.17% 18TCr
Average -0.30%-3.73%+26.41%+54.67% 37.54TCr
Weighted average by Cap. -0.09%-3.57%+28.99%+68.44%

Financials

2027 *2028 *
Net sales 4,70400Cr 2.98TCr 2.66TCr 2.47TCr 2.25TCr 4.24TCr 2,86700Cr 4.27TCr 30TCr 12TCr 1,46300Cr 11TCr 11TCr 4,79400Cr 3.03TCr 2.71TCr 2.52TCr 2.3TCr 4.32TCr 2,92200Cr 4.35TCr 30TCr 12TCr 1,49100Cr 11TCr 11TCr
Net income 20TCr 124.37Cr 110.95Cr 103.36Cr 94Cr 177.14Cr 12TCr 178.45Cr 1.25TCr 485.93Cr 6.11TCr 466.87Cr 456.8Cr 32TCr 204.26Cr 182.22Cr 169.76Cr 154.49Cr 290.94Cr 20TCr 293.09Cr 2.05TCr 798.08Cr 10TCr 766.79Cr 750.25Cr
Net Debt 3,90700Cr 2.47TCr 2.21TCr 2.05TCr 1.87TCr 3.52TCr 2,38100Cr 3.55TCr 25TCr 9.66TCr 1,21500Cr 9.28TCr 9.08TCr 3,70200Cr 2.34TCr 2.09TCr 1.95TCr 1.77TCr 3.34TCr 2,25700Cr 3.36TCr 24TCr 9.16TCr 1,15200Cr 8.8TCr 8.61TCr
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Employees
47,029
Date Price Change Volume
05/26/05 JP¥5,639.00 -0.07% 32,69,900
02/26/02 JP¥5,643.00 -1.54% 42,17,900
01/26/01 JP¥5,731.00 -0.85% 42,31,700
30/26/30 JP¥5,780.00 +0.71% 52,43,000
29/26/29 JP¥5,739.00 -3.22% 48,44,600
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
5,643.00JPY
Average target price
6,622.06JPY
Spread / Average Target
+17.35%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4502 Stock